David D. Halbert serves as Executive at Caris Life Sciences, Inc., where they oversee executive responsibilities. Since joining the company, David D. Halbert has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 11, 2025 involved selling 141,956 shares valued at $4.2M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 11, 2025 | CAI | $4.2M | Payment | 141,956 | $29.75 | Discretionary |
David D. Halbert currently holds 2,295,133 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David D. Halbert has been a net neutral trader of CAI stock. They have purchased $0 and sold $0 worth of shares.
David D. Halbert's most recent insider trade was on Aug 11, 2025, when they sold 141,956 shares at $29.75 per share.
Get notified when new Form 4 filings are submitted